Areas of Focus
- Basic and clinical research on recurrence and metastasis of hepatocellular carcinoma
Work Experience
- 2005/07–2006/11 - Anhui Provincial Hospital, Liver Surgery - Resident Physician
- 2006/12–2012/11 - Anhui Provincial Hospital, Liver Surgery - Attending Physician
- 2012/12–2023/10 - The First Affiliated Hospital of USTC, Liver Surgery - Associate Chief Physician
- 2023/10–Present - The First Affiliated Hospital of USTC, Liver Surgery - Chief Physician
Academic Background & Achievements
- 2002/09–2005/06 Master's in Surgery (General Surgery): Anhui Medical University
- 2008/09–2011/06 Doctorate in Clinical Medicine: Tianjin Medical University
Publications
- Analysis of the safety and effectiveness of TACE combined with targeted immunotherapy in the treatment of intermediate and advanced hepatocellular carcinoma., Liu W, Xie Z, Shen K, Jiang L, Liu C, Ge Y, Yu J, Jia W, Ma J, Chen H., 2023
- Application Effect of ICG Fluorescence Real-Time Imaging Technology in Laparoscopic Hepatectomy., Chen H, Wang Y, Xie Z, Zhang L, Ge Y, Yu J, Zhang C, Jia W, Ma J, Liu W., 2022
- Peroxiredoxin 4 suppresses anoikis and augments growth and metastasis of hepatocellular carcinoma cells through the β-catenin/ID2 pathway., Wang W, Shen XB, Huang DB, Jia W, Liu WB, He YF., 2019
- Expression of LAMP3 and its correlation with clinicopathologic characteristics and prognosis in hepatocellular carcinoma., Gui Y, Liu WB, Chen H, Ma JL, Li JS., 2018
- Knockdown of GTPBP4 inhibits cell growth and survival in human hepatocellular carcinoma and its prognostic significance., Liu WB, Jia WD, Ma JL, et al., 2017